Ed Sitar

Ed Sitar is a passionate and driven CFO with extensive experience in the healthcare, biotech, medical device, and pharmaceutical industries, focusing on both public and private companies. Notably, they held key financial leadership roles at various organizations, including Cancer Genetics, Cadent Holdings, and 9 Meters Biopharma, where they successfully raised significant capital and implemented cost-saving measures. Ed earned recognition as the NJBIZ CFO of the Year for Public Company in 2015. Currently, Ed serves as the Chief Financial Officer at PreciseDx, where they are preparing the company for commercialization and have already streamlined the finance function and raised $11.2 million.